Immediate Impact
7 from Science/Nature 68 standout
Citing Papers
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
2024 Standout
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options
2024 Standout
Works of Mary E. Hanson being referenced
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence
2018
Thirty-Day Readmissions in Hospitalized Patients Who Received Bezlotoxumab With Antibacterial Drug Treatment for Clostridium difficile Infection
2017
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Mary E. Hanson | 645 | 203 | 203 | 230 | 215 | 60 | 1.2k | |
| Tisha Joy | 620 | 96 | 120 | 147 | 406 | 38 | 1.7k | |
| Ikunosuke Sakurabayashi | 808 | 91 | 230 | 75 | 229 | 117 | 1.6k | |
| Steven G. Simonson | 392 | 125 | 85 | 79 | 157 | 33 | 1.3k | |
| Jeong‐Gun Park | 983 | 297 | 161 | 55 | 234 | 59 | 1.5k | |
| Robert Cramb | 701 | 93 | 121 | 49 | 365 | 50 | 1.6k | |
| José María Mostaza | 811 | 265 | 87 | 62 | 255 | 132 | 1.6k | |
| Ariel Hammerman | 91 | 154 | 92 | 335 | 198 | 63 | 1.1k | |
| Sony Tuteja | 308 | 61 | 61 | 74 | 106 | 70 | 1.3k | |
| Amir Kashani | 553 | 134 | 75 | 38 | 203 | 42 | 1.4k | |
| Nidhi Rohatgi | 320 | 22 | 159 | 116 | 414 | 49 | 1.6k |
All Works
Login with ORCID to disown or claim papers
Loading papers...